1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow CG-0416: new trials by email Literature Review of CG-0416 trials Research Report on CG-0416
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants. CG-0416 - Overweight and Obesity | Phase 1 | Not yet recruiting | HongKong Curegene Innovation Co., Limited | 64 | 2026-07-01 | 2026-07-24 |
Obesity (1) · Overweight (1) · Weight Loss (1)
HongKong Curegene Innovation Co., Limited (1)
Australia (1)
Philip Ryan, MD (1)